Back to Trades
Mahaney Paige
Chief Scientific OfficerCIK 0002040313
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Across 1 filing between 2026, Mahaney Paige, Chief Scientific Officer, has disclosed $4.6K in transactions — all concentrated in C4 Therapeutics, Inc. (CCCC). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Feb 18 | CCCC C4 Therapeutics, Inc. | Mahaney Paige | Chief Scientific Officer | Grant | $4.6K |
1 filing